These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4988047)

  • 1. Inactivated smallpox vaccine. A comparison of inactivation methods.
    Turner GS; Squires EJ; Murray HG
    J Hyg (Lond); 1970 Jun; 68(2):197-210. PubMed ID: 4988047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus.
    Turner GS; Squires EJ
    J Gen Virol; 1971 Oct; 13(1):19-25. PubMed ID: 5130569
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivated eastern equine encephalomyelitis vaccines prepared in monolayer and concentrated suspension chick embryo cultures.
    White A; Berman S; Lowenthal JP
    Appl Microbiol; 1971 Nov; 22(5):909-13. PubMed ID: 5132097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunogenicity of heat-inactivated vaccinia virus in rabbits.
    Madeley CR
    J Hyg (Lond); 1968 Mar; 66(1):89-107. PubMed ID: 4967145
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of ethyl alcohol and beta-propiolactone inactivated vaccinia virus on the development of skin immunity and the production of hemagglutination inhibiting antibodies in guinea pigs, rabbits and monkeys.
    Lybing S; Hedström KG
    Z Immunitatsforsch Exp Klin Immunol; 1975 May; 149(1):37-60. PubMed ID: 127456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the antigenic and immunogenic properties of neurovaccinia virus TS mutants.
    Chernos VI; Vasilieva NN; Antonova TP; Surgay VV
    Arch Virol; 1975; 47(2):89-96. PubMed ID: 1119943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune response of the rabbit to smallpox vaccines].
    Musetescu M
    J Biol Stand; 1974 Jul; 2(3):231-41. PubMed ID: 4372233
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of interval between inoculation of live smallpox and yellow-fever vaccines on antigenicity in man.
    Tauraso NM; Myers MG; Nau EV; O'Brien TC; Spindel SS; Trimmer RW
    J Infect Dis; 1972 Oct; 126(4):362-71. PubMed ID: 4672744
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccinia virus strain differences. II. Altered dermal reactivity of vaccinia virus by single passage in a new host system.
    Dunlap RC; Barker LF
    Arch Gesamte Virusforsch; 1973; 42(2):117-24. PubMed ID: 4747046
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of formalin, beta-propiolactone, merthiolate, and ultraviolet light upon influenza virus infectivity chicken cell agglutination, hemagglutination, and antigenicity.
    Goldstein MA; Tauraso NM
    Appl Microbiol; 1970 Feb; 19(2):290-4. PubMed ID: 5437304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ["Rescue" of the rct40 plus-marker of vaccinia virus in different methods of inactivation of the donor virus].
    Sitnikov BS; Gendon IuZ
    Vopr Virusol; 1970; 15(3):278-83. PubMed ID: 5472067
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations on photodynamic inactivation of vaccinia virus and its effect on immunogenicity.
    Turner GS; Kaplan C
    J Hyg (Lond); 1965 Sep; 63(3):395-410. PubMed ID: 5212840
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization against smallpox.
    Kaplan C
    Br Med Bull; 1969 May; 25(2):131-5. PubMed ID: 4918528
    [No Abstract]   [Full Text] [Related]  

  • 14. ANTIRABIES ANTIBODY RESPONSE IN MAN TO VACCINE MADE FROM INFECTED SUCKLING-MOUSE BRAINS.
    FUENZALIDA E; PALACIOS R; BORGONO JM
    Bull World Health Organ; 1964; 30(3):431-6. PubMed ID: 14163964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal experimental studies on oral immunization with vaccinia virus. I].
    Hochstein-Mintzel V; Huber H; Stickl H
    Zentralbl Bakteriol Orig; 1969 Dec; 212(1):41-9. PubMed ID: 5386253
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance of the region of DNA coding ts40 marker of vaccinia virus to certain inactivating factors. Brief report.
    Ghendon YZ; Sitnikov BS
    Arch Gesamte Virusforsch; 1970; 29(1):101-4. PubMed ID: 5452661
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A; Baljer G; Wagner C; Sailer J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of poliovirus with beta-propiolactone.
    Jiang SD; Pye D; Cox JC
    J Biol Stand; 1986 Apr; 14(2):103-9. PubMed ID: 3020055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance of viruses of the subgroup smallpox-vaccinia to treaments primarily damaging the protein coat of the nucleic component of the virus].
    Sitnikov BS; Gendom IuZ
    Vopr Virusol; 1968; 13(5):554-60. PubMed ID: 4303594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.